Related Experiment Video
Updated: Dec 25, 2025
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.7K
Recent advances in mRNA vaccine technology.
Norbert Pardi1, Michael J Hogan2, Drew Weissman1
1Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Current Opinion in Immunology
|April 4, 2020
Summary
Messenger RNA (mRNA) vaccines show promise for treating cancer and infectious diseases. Innovations in delivery materials and mRNA production are key to their success and future development.
Area of Science:
- Biotechnology
- Vaccinology
- Immunology
Background:
- Messenger RNA (mRNA) vaccines are a novel vaccine class.
- They demonstrate potential in combating cancers and infectious pathogens.
- Conventional vaccines may not always induce sufficient immune responses.
Purpose of the Study:
- To summarize recent advancements in mRNA vaccine technology.
- To discuss challenges and future directions in the field.
Main Methods:
- Review of recent scientific literature on mRNA vaccines.
- Analysis of innovations in mRNA delivery and production.
Main Results:
- Recent innovations include safe and efficient in vivo mRNA delivery systems.
- Advanced protocols for high-quality mRNA production have been developed.
- These advancements underpin the efficacy of mRNA vaccines.
Conclusions:
- mRNA vaccines represent a promising future in vaccinology.
- Continued innovation in delivery and production is crucial.
- The field faces challenges but holds significant potential for future applications.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
845
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
845
01:31Hybridoma Technology
17.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.0K
02:31Nuclear Export of mRNA
8.5K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.5K
02:51mRNA Stability and Gene Expression
3.3K
3.3K
02:33Initiation of Translation
38.1K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.1K